Investor sentiment around small-cap companies is worse than it’s been in months. As it turns out, the mood isn’t much better ...
Hosted on MSN22m
How Canada Wins: ‘We can dig deeper’This is Part 1 in our contribution to Postmedia’s national series “How Canada Wins.” Over the next five weeks we’ll chronicle ...
WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical ...
GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback